Home › Asthma › Texas › El Paso
Asthma clinical trials in El Paso, TX
4 studies for Asthma are looking for participants at sites in and around El Paso (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
RecruitingPhase 3
- Research Site, El Paso
A Study to Learn About the Study Medicine Called Tilrekimig ( PF-07275315) in People With Severe Asthma
RecruitingPhase 3
- Western Sky Medical Research, El Paso
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
RecruitingPhase 2
- Research Site, El Paso
Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects
RecruitingObservational study
- Western Sky Medical Research, El Paso
About Asthma
Asthma is a chronic lung disease. It causes asthma attacks, which make your airways inflamed and narrowed, and your lungs get less air. Learn about treatments.
More about Asthma on MedlinePlus
Asthma trials in other cities
- Miami, FL13 studies
- New York City, NY11 studies
- Boston, MA11 studies
- The Bronx, NY10 studies
- Dallas, TX10 studies
- Houston, TX9 studies
- Kansas City, KS9 studies
- Durham, NC9 studies
- St. Louis, MO9 studies
- Oklahoma City, OK9 studies
- Washington, DC9 studies
- Charlotte, NC7 studies
Other studies in El Paso
- Obesity8 studies
- Breast Cancer7 studies
- Non-Small Cell Lung Cancer6 studies
- Overweight6 studies
- Heart Failure6 studies
- Metastatic Cancer5 studies
- COPD5 studies
- Idiopathic Pulmonary Fibrosis5 studies
- Burkitt Lymphoma4 studies
- Alzheimer's Disease4 studies
- Migraine4 studies
- Graves Disease4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.